[HTML][HTML] Costs and healthcare utilisation of patients with heart failure in Spain
C Escobar, L Varela, B Palacios, M Capel… - BMC Health Services …, 2020 - Springer
Background Increasing the knowledge about heart failure (HF) costs and their determinants
is important to ascertain how HF management can be optimized, leading to a significant …
is important to ascertain how HF management can be optimized, leading to a significant …
[HTML][HTML] Costs and healthcare utilisation of patients with chronic kidney disease in Spain
C Escobar, B Palacios, U Aranda, M Capel… - BMC Health Services …, 2021 - Springer
Background Data about the impact of chronic kidney disease (CKD) on health care costs in
Spain are scarce This study was aimed to evaluate cumulative costs and healthcare …
Spain are scarce This study was aimed to evaluate cumulative costs and healthcare …
[HTML][HTML] Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain
C Escobar, U Aranda, B Palacios, M Capel, A Sicras… - nefrologia, 2021 - Elsevier
Objectives To describe the epidemiology, clinical profile, treatments, and to determine
cardiovascular and renal outcomes after two years of follow-up in a contemporary chronic kidneay …
cardiovascular and renal outcomes after two years of follow-up in a contemporary chronic kidneay …
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very …
…, C Escobar, U Aranda, B Palacios, M Capel… - Clinical Kidney …, 2022 - academic.oup.com
Chronic kidney disease (CKD) is a common condition worldwide [1]; however, it is vastly
underdiagnosed as it frequently remains asymptomatic until reaching advanced stages [2]. Thus…
underdiagnosed as it frequently remains asymptomatic until reaching advanced stages [2]. Thus…
Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain
A Sicras-Mainar, M Capel… - Journal of Medical …, 2020 - Taylor & Francis
Objective: We determined the percentage of patients with severe asthma and exacerbations
and evaluated the costs of the disease based on blood eosinophil counts. Methods: A …
and evaluated the costs of the disease based on blood eosinophil counts. Methods: A …
[HTML][HTML] Primary vs. Secondary Heart Failure Diagnosis: differences in clinical outcomes, healthcare resource utilization and cost
Background. There is scarce information on patients with secondary heart failure diagnosis (sHF).
We aimed to compare the characteristics, burden and outcomes of sHF with those with …
We aimed to compare the characteristics, burden and outcomes of sHF with those with …
[HTML][HTML] Cost-effectiveness analysis of dapagliflozin for the treatment of type 2 diabetes mellitus in Spain: results of the DECLARE-TIMI 58 study
Background The objective of this study was to carry out a cost-effectiveness analysis of
dapagliflozin, as an add-on therapy to standard of care (SoC), for the treatment of type 2 diabetes …
dapagliflozin, as an add-on therapy to standard of care (SoC), for the treatment of type 2 diabetes …
Efficiency of naproxen/esomeprazole in association for osteoarthrosis treatment in Spain
M Capel, J Tornero, JL Zamorano, I Oyagüez… - … Clínica (English Edition), 2014 - Elsevier
Objective To assess, from the perspective of the National Healthcare System, the efficiency
of a fixed-dose combination of naproxen and esomeprazole (naproxen/esomeprazole) in the …
of a fixed-dose combination of naproxen and esomeprazole (naproxen/esomeprazole) in the …
A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain
…, E Calvo, M Muñoz, R Ampudia, M Capel - Journal of …, 2011 - Taylor & Francis
Objective. To study the effectiveness and safety in a real-life setting of budesonide/formoterol
(Symbicort) Maintenance And Reliever Therapy® (Symbicort SMART®), a simplified …
(Symbicort) Maintenance And Reliever Therapy® (Symbicort SMART®), a simplified …
Cost-effectiveness of fixed-dose combinations therapies for chronic obstructive pulmonary disease treatment
M Capel, M Mareque, CJ Álvarez, L Lindner… - Clinical Drug …, 2018 - Springer
Background and Objective Chronic obstructive pulmonary disease (COPD), a progressive
lung disorder associated with decline of respiratory function, affects 10.2% of Spanish adults (…
lung disorder associated with decline of respiratory function, affects 10.2% of Spanish adults (…